A new antibiotic, substance SF-1771, has been isolated from the fermentation broth of Streptomyces toyocaensis SF-1771. The antibiotic is highly active against Gram-positive and -negative bacteria and effective against sarcoma 180 cells of ascites type in mice . It belonged to the phleomycin-bleomycin group antibiotics, but has been differentiated from the known antibiotics by the physicochemical properties, chromatographic behaviours and amino acid analysis.
In the course of our screening for new antibiotics, a novel basic antibiotic was isolated from the culture filtrate of Streptomyces toyoccrensis SF-1771. The strain was isolated from a soil sample collected at Takehara city, Hiroshima prefecture, Japan. This paper deals with the production, isolation, purification and physico-chemical and biological properties of substance SF-1771.
Characterization of the Producing Microorganism
For the taxonomic characterization of the strain SF-1771, the methods of the International Streptomyces Project (ISP) by SHIRLING and GOTTLIEB1) were used, with additional media recommended by WAKSMAN2). The strain SF-1771 showed the following morphological, cultural and physiological characteristics: Aerial mycelium indicated monopodial branching with spiral spore chains on most of the media tested. The spores were in chains of more than ten, ellipsoidal in shape, 0. A pale yellow powder of copper-free SF-1771 substance was obtained by treating the methanolic solution of copper-complex with hydrogen sulfide followed by chromatography over Sephadex LH-20.
So far, no minor component has been detected during column chromatography. and some other related compounds are shown in Table 2 and Fig. 2 . The IR spectrum of copper-free form in KBr pellet is presented in Fig. 3 . Strong absorptions are observed at 3400 -i 3200 cm -1 (OH/ NH), 1720 cm-1 (OCONH2), 1650 and 1550 cm -1 (CONH) and 1120-1020 cm -1 (C-O-).
The 1H-NMR spectrum of copper-free hydrochloride is shown in Fig. 4 . The minimum inhibitory concentration (MIC) of SF-1771 was determined by the agar dilution method, and the results are given in Table 3 . It showed strong antibacterial activity against Gram-THE  JOURNAL  OF ANTIBIOTICS  NOV.  1980 positive and -negative bacteria. Table 4 showed the antitumor activity against sarcoma 180 of mouse ascites type. SF-1771 (copper-free) was most effective by intraperitoneal administration of 4 mg/kg/day. It was inactive against leukemia L-1210 in mice.
The LD50 of copper-chelated and copper-free forms were about 10 mg/kg and 20 mg/kg respectively, by intravenous injection to mice. It showed negative mutagenecity test (rec assay) when examined by the streak and paper disc method using a mutant of Bacillus subtilis as a test organism. The relative rate of inactivation against rat liver enzyme of SF-1771 (copper-free) and bleomycin A2 was compared.
This antibiotic was evidently more stable than bleomycin A2 against 100S fraction of rat liver homogenate, as shown in Table 5 . The daily intraperitoneal injection of SF-1771 (Cu-free) for 3 days was started 24 hours after the intraperitoneal transplantation of 1.14x 106 tumor cells. From the physico-chemical and biological properties described above, SF-1771 substance seems to belong to the bleomycin-phleomycin antibiotic. From the ratio of two UV maxima at 248 and 282-284 nm (1.38), SF-1771 substance is more similar to bleomycins4), cleomycin5), phleomycin (C,D2 and F)4), zorbonomycin7), victomycine', platomycin (A and B)9) and tallysomycins10) rather than phleomycins6), zorbamycin7), zorbonomycin C7), YA-56X11) and SS-7012) (ratio of 2.7-3.0).
The negative SAKAGUCHI reaction of SF-1771 further differentiated the B group of bleomycins, victomycin and platomycins, all of which gave positive SAKAGUCHI reaction13,14). SF-1771 seemed to be different from any other bleomycin group antibiotics including zorbonomycin B and tallysomycins as judged from various chromatographic systems.
The novelty of SF-1771 was strongly supported by degradation studies of it. Gulose and 3-0-carbamoyl-mannose, common sugar moieties of all bleomycins, were found to be sugar components of SF-1771 by GC-MS analysis of its methanolyzate, however, SF-1771 was found to possess unique amino acid components. It is still not clear whether an amino sugar is present, as found in tallysomycins, or not, however, CMR spectrum of SF-1771 suggested the presence of an extra sugar at 96.0 ppm. TLC (Avicel) coupled with high voltage electrophoresis (pH 1.8) of acid hydrolyzate of SF-1771 revealed the presence of six ninhydrin positive spots, in which four spots were identified as threonine (I)*, 4-amino-3-hydroxy-2-methyl-n-valeric acid (III)*, B-hydroxy-histidine (IV)* and B-aminoalanine (V)*. The spot corresponding to B-amino-B-(4-amino-6-carboxy-5-methylpyrimidin-2-yl)-propionic acid (II)* was not detected, however, the compound with lowest mobility on TLC seemed to be demethyl-II15a, b) judging from its ninhydrin-coloration and its Rf value.
Finally, this amino acid was identified as B-amino-B-(4-amino-6-carboxy-pyrimidin-2-yl)-propionic acid (demethyl-II) by the direct comparison with an authentic sample16). In the 1H-NMR spectrum of SF-1771, no aromatic methyl signal was observed around 3 ppm region and instead, an extra olefin proton assignable to H-5 in demethyl-II was observed in the lowest field region of the spectrum. All bleomycin group antibiotics so far reported possessed II in common and demethyl-II was only found, in the biosynthetic intermediates of bleomycin isolated from the culture broth of Streptomyces verticillus.15a, b) Therefore, SF-1771 is the first bleomycin-phleomycin group antibiotic possessing demethyl-II instead of II. 1H-NMR spectrum of SF-1771 also suggested the presence of a bithiazole component, however, 2'-(2-aminoethyl)-2,4'-bithiazole-4-carboxylic acid (VI)* could not be detected in acid hydrolyzate. Since 2'-polyfunctionally substituted bithiazole carboxylic acid (VI') was reported to decompose during acid hydrolysis18), SF-1771 was considered to contain VI' type of compound.
It is also interesting that no terminal amine component found in bleomycins was found in SF-1771.
We have also isolated another bleomycin group antibiotic possessing demethyl-II, SF-1961, whose detail is given in the following paper19).
